RossLab

Based at Aston University, Department Health and Life Sciences. Research areas: Mesenchymal Stromal Cells, Ageing, Regenerative Medicine and Tissue Engineering

[British Society for Research on Ageing @BSRAgeing]

Meet @JaspreetkBansal and @J_W_Lewis, joint winners of this year's ECR writing competition at #BSRA2024. Should we publish their essays on our website? Let us know below!

Thanks to the @BBSRC for sponsoring

[Jaspreet Kaur Bansal @JaspreetkBansal]

Last week I had the great opportunity to present my data at the @UkAgeing
and @BSRAgeing meetings where there was some great talks on ageing and senescence.

I also received joint 1st for the @BBSRC ECR Writing competition.

#BSRA2024 @MIBTP1 @AstonUniversity

[Hannah Donnelly @hannahdonnelly_]

Beyond delighted to share our latest work from @theglasgowcemi @DalbyMatthew @ManuelMime, published yesterday in @NatureComms. Here we bioengineer a model of the bone marrow niche microenvironment that can maintain long-term HSCs 🦴🩸
https://t.co/HMO4oAodKx

[Mesenchymal Cell News @MesenchymalCell]

Give it up for the @RossLabGroup group, coming in at #3 in our Top Posts Countdown! 🥳 They reported on how nanotopography can control the immunomodulatory capacity of MSCs. Give their paper a read if you haven't already! 👓

https://t.co/OqmxBDVuZm

[Jaspreet Kaur Bansal @JaspreetkBansal]

I'm grateful for the opportunity to present my data for the first time at the @BSRAgeing. The conference was so insightful and well organised. Thank you also to the UKRI MRC National Musculoskeletal ageing network for funding my travel to attend. @MIBTP1 @AstonUniversity

[Jennifer Willis @JennWillis_]

1/ Upscaling #MesenchymalStromalCell (#MSCs) cultures for therapy.

The current annual incidence of #autoimmune conditions is increasing by a rate of 3- 9% worldwide, with ~4 million of the UK population afflicted.

These are highlighted by the loss of immune cell #tolerance.

[MIBTP @MIBTP_BBSRC]

MIBTP Student, @JaspreetkBansal, has published an article in the journal, Nature Communications.

Titled as 'Nanotopography reveals metabolites that maintain the immunomodulatory phenotype of mesenchymal stromal cells'

Read here: https://t.co/8iLxDUB6Db

#lifesciences #MIBTP

[Mesenchymal Cell News @MesenchymalCell]

An exciting study 💡 led by Dr. Matthew Dalby (@DalbyMatthew) and colleagues @RossLabGroup 👨‍🔬👩‍🔬 demonstrate an effective route to support large-scale expansion of functional #MSCs for therapeutic purposes.

Find out more about this study:
👉 https://t.co/zSs3razHla

[Matt Dalby @DalbyMatthew]

Congrats @RossLabGroup - this great paper in
@NatureComms demonstrates (1) that nanotopography can maintain immunomodulatory MSC phenotype and (2) identify activity metabolites to be identified allowing large scale culture.

https://t.co/NkX742Ors8

[Megan Boseley @megan_boseley]

UKEV conference in Edinburgh🤩 and first outing with the @RossLabGroup 🔬 Looking forwards to some interesting talks 👏🏻 @UKEVSoc

[LifETIME-CDT @CDTLifETIME]

Anti-Inflammatory Therapeutics: The Knee-d to Change our Approach

Read our latest blog by @JennWillis_ from @AstonUniversity

https://t.co/j2Dm0yke1Y

[Jaspreet Kaur Bansal @JaspreetkBansal]

Myself and @rs_butler held our 1st #MacmillanCoffeeMorning with @AstonBioscience. We managed to smash our target of £100 with your generous donations and raise £514 for @macmillancancer! Thank you to everyone who baked and donated!

[Johnson Lab @JJohnsonLab]

Congratulations to our PhD student @AnneliseGar for passing her qualifying report viva which allows her to formally progress to 2nd year of her PhD. Had a great time celebrating with @RossLabGroup!

[RossLab @RossLabGroup]

Congratulations to both @JaspreetkBansal and @JennWillis_ for passing their 1st year qualifying vivas last week. Great to celebrate with @JJohnsonLab too! @MIBTP1 @CDTLifETIME

[Babraham Institute @BabrahamInst]

BLOG: #PhD student @JaspreetkBansal @AstonUniversity joined our #KnowledgeExchange team for her PIPS project. Hear about her experience of KEC and Institute life in our latest blog post:
https://t.co/bsLuRA6VBJ